Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,944 | 8 | 42.8% |
| Honoraria | $3,900 | 3 | 28.1% |
| Travel and Lodging | $2,586 | 4 | 18.6% |
| Food and Beverage | $1,466 | 36 | 10.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Impulse Dynamics (USA) Inc. | $7,917 | 12 | $0 (2023) |
| Edwards Lifesciences Corporation | $5,044 | 9 | $0 (2023) |
| Amgen Inc. | $155.35 | 7 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $150.42 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $142.60 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $103.79 | 4 | $0 (2024) |
| PFIZER INC. | $86.59 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $67.33 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $66.65 | 1 | $0 (2022) |
| Kiniksa Pharmaceuticals International, plc | $44.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $351.36 | 10 | Lexicon Pharmaceuticals, Inc. ($120.54) |
| 2023 | $1,699 | 12 | Impulse Dynamics (USA) Inc. ($1,045) |
| 2022 | $10,776 | 24 | Impulse Dynamics (USA) Inc. ($5,872) |
| 2021 | $1,069 | 5 | Impulse Dynamics (USA) Inc. ($1,000) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Cardiology | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/29/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $44.35 | General |
| Category: Not Applicable | ||||||
| 07/18/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $120.54 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 06/25/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Diabetes | ||||||
| 03/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: DIABETES | ||||||
| 02/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 12/05/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardiology | ||||||
| 11/21/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/09/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/06/2023 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $43.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/29/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Cardiology | ||||||
| 06/20/2023 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $363.00 | General |
| 06/06/2023 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/23/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $43.36 | General |
| 02/23/2023 | Boston Scientific Corporation | EkoSonic (Device) | Food and Beverage | In-kind items and services | $35.23 | General |
| Category: EkoSonic_PI | ||||||
| 01/30/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Travel and Lodging | Cash or cash equivalent | $1,044.80 | General |
| Category: Cardiovascular Device | ||||||
| 01/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/09/2022 | Impulse Dynamics (USA) Inc. | Optimizer (Device) | Honoraria | Cash or cash equivalent | $1,200.00 | General |
| Category: Cardiovascular | ||||||
| 12/01/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Cardiology | ||||||
| 10/28/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 790 | 1,112 | $420,773 | $91,166 |
| 2022 | 10 | 713 | 1,019 | $347,353 | $74,545 |
| 2021 | 14 | 677 | 1,024 | $285,852 | $64,862 |
| 2020 | 11 | 466 | 626 | $134,095 | $29,728 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 280 | 380 | $225,856 | $47,853 | 21.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 76 | 218 | $78,014 | $18,903 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 119 | $50,541 | $10,763 | 21.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 57 | $35,493 | $6,919 | 19.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 43 | $10,022 | $2,480 | 24.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 18 | 21 | $8,937 | $1,734 | 19.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 119 | 129 | $9,568 | $1,296 | 13.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 120 | 145 | $2,342 | $1,218 | 52.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 168 | 203 | $121,597 | $26,376 | 21.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 96 | 270 | $89,098 | $20,058 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 176 | $75,604 | $15,342 | 20.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 44 | 49 | $21,274 | $4,790 | 22.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 29 | 39 | $16,743 | $3,664 | 21.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 23 | 24 | $7,724 | $1,606 | 20.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 14 | 14 | $4,264 | $757.39 | 17.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $4,249 | $753.09 | 17.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 74 | 78 | $5,432 | $748.15 | 13.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 123 | 152 | $1,368 | $449.79 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 184 | 278 | $110,910 | $25,369 | 22.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 107 | 254 | $59,414 | $13,255 | 22.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 64 | 125 | $41,807 | $9,338 | 22.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $14,215 | $3,239 | 22.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 26 | $14,230 | $3,214 | 22.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 36 | 38 | $12,497 | $2,716 | 21.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 22 | $9,724 | $2,197 | 22.6% |
About Stacey Gross, NP
Stacey Gross, NP is a Nurse Practitioner healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1760720221.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacey Gross, NP has received a total of $13,896 in payments from pharmaceutical and medical device companies, with $351.36 received in 2024. These payments were reported across 51 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($5,944).
As a Medicare-enrolled provider, Gross has provided services to 2,646 Medicare beneficiaries, totaling 3,781 services with total Medicare billing of $260,301. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Adult Health, Acute Care
- Location Los Angeles, CA
- Active Since 01/17/2013
- Last Updated 06/28/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1760720221
Products in Payments
- Optimizer (Device) $5,872
- OPTIMIZER (Device) $1,045
- Optimizer Smart System (Device) $1,000
- Inpefa (Drug) $150.42
- XARELTO (Drug) $142.60
- Repatha (Biological) $111.26
- JARDIANCE (Drug) $67.33
- CAMZYOS (Drug) $66.65
- ENTRESTO (Drug) $52.41
- LEQVIO (Drug) $51.38
- Arcalyst (Drug) $44.35
- Corlanor (Drug) $44.09
- ELIQUIS (Drug) $43.59
- VYNDAMAX (Drug) $43.00
- EkoSonic (Device) $35.23
- Ozempic (Drug) $24.93
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $24.54
- FUROSCIX (Drug) $23.82
- OPSUMIT (Drug) $20.41
- WAINUA (Drug) $13.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Los Angeles
Hamideh Pourzand, Rn, Np, Msn, RN, NP, MSN
Nurse Practitioner — Payments: $61,113
Leslie Tarlow, N.p, N.P
Nurse Practitioner — Payments: $39,544
Janet Gripshover, Crnp, CRNP
Nurse Practitioner — Payments: $23,122
Ms. Jean James, Rnp, RNP
Nurse Practitioner — Payments: $20,852
Barbara Quinn, Np, NP
Nurse Practitioner — Payments: $18,340
Ann Easley, Np, NP
Nurse Practitioner — Payments: $14,549